UTI INC. Completes 10 Billion Won 6th CB Issuance for Refinancing, Dilution Risk Persists
UTI INC. completed the issuance of the 6th unregistered, unsecured private convertible bond worth 10 billion KRW on May 29, 2026.
The conversion price is 21,178 KRW, and the new shares to be issued upon conversion are 472,188 shares (2.28% of outstanding shares), with a total potential dilution of 24.78% including existing outstanding CBs.
All 10 billion KRW raised will be used to repay the existing 1st CB (balance 23.9 billion KRW) to improve financial structure.
Investors can exercise a put option every 3 months from November 29, 2028, with the initial early redemption rate set at 105.114%.
The issuer can call up to 30% of the bonds every 3 months from May 29, 2027 to May 29, 2028, with a 2% annual compound interest added to the purchase price.
The conversion price is reset every 7 months, with a floor of 14,825 KRW (70% of the issue price). Upward adjustment is possible but limited to the issue price.
Tag-along rights are granted, allowing investors to participate in any sale of the largest shareholder's stake under the same conditions.
[AI Comprehensive Analysis]This CB issuance is essentially a refinancing to extend debt maturity, not new capital raising. While the immediate dilution is low at 2.28%, the total potential dilution including existing CBs reaches 24.78%, posing long-term shareholder value risk. Additionally, the investor-friendly put option and potential conversion price reset in case of stock price decline may lead to further dilution, requiring cautious investment.
KOSDAQ Filing Information
Filing: Securities Issuance Result (Voluntary Disclosure) (6th Series Convertible Bond)